PK-PD of antifungal drugs: from preclinical data to clinical applications

被引:0
|
作者
Mazzei, T. [1 ]
机构
[1] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
下载
收藏
页码:S7 / S7
页数:1
相关论文
共 50 条
  • [1] PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology
    Lees, P
    Giraudel, J
    Landoni, MF
    Toutain, PL
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) : 491 - 502
  • [2] Clinical evidence of PK/PD of antifungal drugs
    Novelli, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S14 - S14
  • [3] PK-PD modeling of protein drugs: implications in assay development
    Roskos, Lorin K.
    Schneider, Amy
    Vainshtein, Inna
    Schwickart, Martin
    Lee, Rozanne
    Lu, Hong
    Faggioni, Raffaella
    Liang, Meina
    BIOANALYSIS, 2011, 3 (06) : 659 - 675
  • [4] PK-PD integration and PK-PD modelling of preferential and selective COX-2 inhibitors: towards safer drugs and improved dosage regimens
    Lees, P.
    Giraudel, J.
    Toutain, P. L.
    Pelligand, L.
    King, J. N.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 : 33 - 36
  • [5] The role of population PK-PD modelling in paediatric clinical research
    De Cock, Roosmarijn F. W.
    Piana, Chiara
    Krekels, Elke H. J.
    Danhof, Meindert
    Allegaert, Karel
    Knibbe, Catherijne A. J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 : S5 - S16
  • [6] PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development
    Oggianu, Laura
    Garrone, Beatrice
    Fiorentini, Francesco
    Del Bene, Francesca
    Rosignoli, Maria Teresa
    Di Giorgio, Francesco Paolo
    Kaminski, Rafal Marian
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (04): : 606 - 617
  • [7] RELEVANCE OF PRECLINICAL PK-PD TO THE CLINICAL IMMUNOMODULATORY (IMMOD) EFFECTS OF FK-506 IN TRANSPLANTATION (TX) AND AUTOIMMUNITY (AL)
    MUKHERJEE, A
    LE, K
    LIEBERMAN, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 149 - 149
  • [9] Preclinical pharmacokinetics-pharmacodynamics (PK-PD) modeling of TAK-733, an investigational MEK inhibitor
    Le, K.
    Chakravarty, A.
    Walker, R.
    Izmailova, E.
    Vincent, P.
    O'Connell, S.
    Prakash, S.
    EJC SUPPLEMENTS, 2010, 8 (07): : 188 - 189
  • [10] Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolation
    Philippe B. Pierrillas
    Emilie Henin
    Julien Ogier
    Magali Amiel
    Laurence Kraus-Berthier
    Marylore Chenel
    François Bouzom
    Michel Tod
    Investigational New Drugs, 2020, 38 : 1796 - 1806